Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals

Patent · Mon Jan 01 00:00:00 EST 1990

OSTI ID:867344

Thakur, Madhukar L ^[1]

---

1. Cherry Hill, NJ

The invention discloses improved reagents containing antibodies against stage specific embryonic antigen-1 antibodies and improved methods for detection of occult abscess and inflammation using the improved reagents.

• Research Organization: Thomas Jefferson University
• DOE Contract Number: FG02-85ER60295
• Assignee: Thomas Jefferson University (Philadelphia, PA)
• Patent Number(s): US 4917878
• OSTI ID: 867344
• Country of Publication: United States
• Language: English

Related Subjects

novel
radiolabelled
antibody
stage
specific
embryonic
antigen
detection
occult
abscesses
mammals
discloses
improved
reagents
containing
antibodies
antigen-1
methods
abscess
inflammation
improved method
specific embryonic
stage specific
improved methods
occult abscess
embryonic antigen-1
embryonic antigen
reagents contain
/424/530/